Skip to main content
. 2014 Feb 18;8(3):360–366. doi: 10.1111/irv.12243

Table 3.

Multivariate analysis of seroconversion rate by baseline characteristics after two doses of vaccine

Characteristic Seroconversion rate (%) Odds ratio (95% CI) P-value
CDC clinical stage
 N/A 8/8 (100) 13·4 (0·66–272) 0·96
 B/C 9/16 (56)
HIV virological suppression
 Yes 15/17 (88) 18·7 (2–170·3) 0·03*
 No 2/7 (29)

Odds ratio calculated using Fisher's exact test. P-value calculated using Wald chi-squared test.

*

statistical significance.